Priority Date: 05.07.12 (US 201261668134P)

OPTIMUM DOSE REGIME OF AN ANTI-NOGO-A ANTIBODY IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

  • Application ID: EP13732986
  • Status: APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
3 offices
Technology Company
no operation time available
3 offices
Technology Company

Specialization

This EP application has the IPC class C07 (ORGANIC CHEMISTRY). GlaxoSmithKline is specialized in C07. GlaxoSmithKline, GlaxoSmithKline is specialised in C07 (ORGANIC CHEMISTRY). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 05.07.2012 - Priority Date (US 201261668134P)
  • 09.01.2014 - Publication A1 (WO2014006105)
  • 13.05.2015 - Publication A1 (EP2870177)

IPC Classification